These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7196763)

  • 1. [Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].
    Pöch G
    Arzneimittelforschung; 1981; 31(7):1135-40. PubMed ID: 7196763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of drug interactions.
    Bijnsdorp IV; Giovannetti E; Peters GJ
    Methods Mol Biol; 2011; 731():421-34. PubMed ID: 21516426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.
    Pöch G; Holzmann S
    J Pharmacol Methods; 1980 Sep; 4(2):179-88. PubMed ID: 7453194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses.
    Fang HB; Ross DD; Sausville E; Tan M
    Stat Med; 2008 Jul; 27(16):3071-83. PubMed ID: 18186545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose factor of potentiation derived from isoboles.
    Pöch G
    Arzneimittelforschung; 1980; 30(12):2195-6. PubMed ID: 7194083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: a critical evaluation.
    Bosgra S; van Eijkeren JC; Slob W
    Crit Rev Toxicol; 2009; 39(5):418-26. PubMed ID: 19514914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the type of overadditive drug interaction under various experimental conditions: differentiation of sequential from functional synergism in dose response studies.
    Pöch G; Schmidt K; Dittrich P
    Methods Find Exp Clin Pharmacol; 1982; 4(6):371-7. PubMed ID: 7144332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the calculation and the evaluation of combinations of active substances (author's transl)].
    Groeger U; Lang S; Michel HJ
    Pharmazie; 1981; 36(2):81-7. PubMed ID: 7232493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of drug interactions in combined drug therapy by reflection method.
    Zheng QS; Sun RY
    Acta Pharmacol Sin; 2000 Feb; 21(2):183-7. PubMed ID: 11263269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical mixture toxicity testing with Vibrio fischeri: combined effects of binary mixtures for ten soft electrophiles.
    Dawson DA; Pöch G; Schultz TW
    Ecotoxicol Environ Saf; 2006 Oct; 65(2):171-80. PubMed ID: 16139365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative design of drug compatibility by weighted modification method.
    Zheng QS; Sun RY
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1043-51. PubMed ID: 11270973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.
    Wojda E; Wlaz A; Patsalos PN; Luszczki JJ
    Epilepsy Res; 2009 Oct; 86(2-3):163-74. PubMed ID: 19596559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms.
    Shafer SL; Hendrickx JF; Flood P; Sonner J; Eger EI
    Anesth Analg; 2008 Aug; 107(2):507-24. PubMed ID: 18633029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug synergism: its detection and applications.
    Tallarida RJ
    J Pharmacol Exp Ther; 2001 Sep; 298(3):865-72. PubMed ID: 11504778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flexible unified approach to the analysis of pre-clinical combination studies.
    Harbron C
    Stat Med; 2010 Jul; 29(16):1746-56. PubMed ID: 20572122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.